Search results
Results from the WOW.Com Content Network
This year, BCRF is the largest private funder of breast cancer research—and metastatic breast cancer research—worldwide and is the highest-rated breast cancer research organization in the country. Nearly half of our annual funding is dedicated to MBC research.
New York, NY – Sept 27, 2023 – The Breast Cancer Research Foundation (BCRF) announced its $60.2 million commitment to fund breast cancer research in 2023-2024, supporting more than 250 scientists at leading academic and medical institutions across 14 countries.
New York, NY – Sept 24, 2024 – The Breast Cancer Research Foundation (BCRF) is investing $70.3 million—BCRF’s largest annual program in its 31-year history— to fund breast cancer research in 2024-2025, supporting more than 260 scientists at leading academic and medical institutions across 15 countries. The investment will span the ...
Through our research program, Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. We’re focused on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities.
IIR Grants provides funding for established independent investigators who seek to explore important issues and novel approaches that will lead to reductions in breast cancer incidence and/or mortality within the next decade.
Breast Cancer Alliance offers grants to providers that conduct screening and diagnostic breast cancer services for the underserved: screening and diagnostic mammograms, biopsies, ultrasounds and MRIs. The programs must be located in Connecticut and/or in Westchester County, New York.
The $19.3 million in new grants support Komen’s mission to end breast cancer through funding two focus areas: advancing precision medicine and eliminating disparities in breast cancer outcomes, while continuing Komen’s commitment to supporting the next generation of diverse leaders in breast cancer research.